TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
01 2TAPI Technology & API Services
02 2Acebright India Pharma Private Limited
03 1Aurobindo Pharma Limited
04 2Cipla
05 2F.I.S. Fabbrica Italiana Sintetici
06 1Formosa Laboratories
07 3Hetero Drugs
08 1Intas Pharmaceuticals
09 1Kyongbo Pharmaceutical Co., Ltd
10 2Laurus Labs
11 2MSN Laboratories
12 1Natco Pharma
13 1PHF SA
14 1Qilu Tianhe Pharmaceutical Co., Ltd.
15 1Reliance Life Sciences Private Limited
16 2Shilpa Medicare
17 1Sichuan Xieli Pharmaceutical
18 1Signa S.A. de C.V.
19 1Sun Pharmaceutical Industries Limited
20 1Tai Heng Industry Co., Ltd
21 1Viatris
22 1Zhejiang Hisun Pharmaceutical
23 1Zhejiang Jiuzhou Pharmaceutical
24 3Zydus Lifesciences
01 17IMATINIB MESYLATE
02 1IMATINIB MESYLATE (A-FORM)
03 1IMATINIB MESYLATE (ALPHA 2-FORM)
04 1IMATINIB MESYLATE (ALPHA FORM)
05 1IMATINIB MESYLATE (AMORPHOUS)
06 2IMATINIB MESYLATE (BETA FORM)
07 1IMATINIB MESYLATE (FORM-A)
08 1IMATINIB MESYLATE (FORM-B)
09 1IMATINIB MESYLATE (IMN)
10 1IMATINIB MESYLATE (NON-STERILE API)
11 1IMATINIB MESYLATE (PROCESS II)
12 1IMATINIB MESYLATE (PROCESS-2)
13 1IMATINIB MESYLATE (ß-FORM)
14 1IMATINIB MESYLATE A-FORM [DRUG SUBSTANCE(NON-STERILE)]
15 1IMATINIB MESYLATE AMORPHOUS
16 1IMATINIB MESYLATE FORM ALPHA
17 1IMATINIB MESYLATE [DRUG SUBSTANCE(NON-STERILE)]
18 1IMATINIB MESYLATE [ROUTE CODE-" IT"]
01 5China
02 21India
03 2Israel
04 2Italy
05 1Mexico
06 1South Korea
07 1Switzerland
08 1Taiwan
09 1U.S.A
01 26Active
02 9Inactive
01 16Complete
02 19Blank
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-11-08
DMF Number : 21006
Submission : 2007-11-02
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2014-08-20
Pay. Date : 2014-04-22
DMF Number : 28182
Submission : 2014-05-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-01
Pay. Date : 2016-09-28
DMF Number : 26170
Submission : 2013-01-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-24
Pay. Date : 2015-12-21
DMF Number : 25206
Submission : 2011-07-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25205
Submission : 2011-07-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-28
Pay. Date : 2013-09-19
DMF Number : 20410
Submission : 2007-04-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24207
Submission : 2011-03-04
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19499
Submission : 2006-06-06
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-03-10
Pay. Date : 2013-12-12
DMF Number : 24838
Submission : 2011-03-26
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23343
Submission : 2009-11-30
Status : Active
Type : II
A Imatinib Mesilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imatinib Mesilate, including repackagers and relabelers. The FDA regulates Imatinib Mesilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imatinib Mesilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imatinib Mesilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imatinib Mesilate supplier is an individual or a company that provides Imatinib Mesilate active pharmaceutical ingredient (API) or Imatinib Mesilate finished formulations upon request. The Imatinib Mesilate suppliers may include Imatinib Mesilate API manufacturers, exporters, distributors and traders.
click here to find a list of Imatinib Mesilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Imatinib Mesilate DMF (Drug Master File) is a document detailing the whole manufacturing process of Imatinib Mesilate active pharmaceutical ingredient (API) in detail. Different forms of Imatinib Mesilate DMFs exist exist since differing nations have different regulations, such as Imatinib Mesilate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Imatinib Mesilate DMF submitted to regulatory agencies in the US is known as a USDMF. Imatinib Mesilate USDMF includes data on Imatinib Mesilate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Imatinib Mesilate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Imatinib Mesilate suppliers with USDMF on PharmaCompass.
We have 24 companies offering Imatinib Mesilate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?